NSE filing, NSE: TANLA. Summary written from the filing by ALFA Finder's alert engine.
Tanla Platforms Ltd: key numbers
- Share price
- ₹598.70
- Market cap
- ₹7,941 Cr
- Revenue (annual)
- ₹4,418 Cr
- Net profit (annual)
- ₹509.1 Cr
- P/E (TTM)
- 14.3×Sector 22.9×
- Promoter holding
- 46.17%+0.00% QoQ
- FII holding
- 8.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tanla Platforms Ltd
All →Tanla Platforms Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹13,517 Mn (+25.3% YoY), EBITDA ₹2,143 Mn (+20.8%), PAT ₹1,464 Mn (+17.1%). Debt-free, cash ₹14,474 Mn, ROCE 27%.
Tanla Platforms Results Update
Tanla reported Q2 FY27 revenue of ₹1,352 Cr, up 25.3% YoY, and PAT of ₹146 Cr. The update came via press release, not a full results statement.
Tanla Platforms Dividend
Tanla Platforms declared a first interim dividend of Rs 6 per equity share for FY 2026-27. The record date for entitlement is 02 November 2026.
Tanla Platforms Q2 FY27 Results: Net Profit ₹146.4 Cr, Up 17.1% YoY
Tanla Platforms Ltd reported revenue from operations of ₹1,352 Cr (+25.3% YoY) and net profit of ₹146.4 Cr (+17.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹146.4 Cr · +17.1% YoY
Tanla Platforms Board Meeting Date
Tanla Platforms will hold a board meeting on October 27, 2026, to consider unaudited financial results and a potential interim dividend.
Tanla Platforms Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31 of the SEBI LODR regulations for the quarter ended September 30, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date